4
Changes in Ownership
Eledon Pharmaceuticals, Inc. Filed Acc 0001209191-15-047656
Options or other derivatives
- General Counsel, Executive VP acquired 214,605 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Quirk Gerald E General Counsel, Executive VP | 2015-05-26 | Grant or award · Stock Option (right to buy) | +214,605 | 214,605 | D | ||
Loading xslF345X03/doc4.xml…